Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesPrognostic factors for lung function in systemic sclerosis: Prospective study of 105 cases
European Respiratory Journal , 06/24/09
Gilson M et al. – Study demonstrates that only diffuse systemic sclerosis (SSc) was predictive of a decrease in pulmonary function in this early-SSc cohort, however does not support a causative role of oesophageal involvement.
Methods- Main objectives of this study were:
- To identify prognostic factors for SSc- interstitial lung disease (ILD), and
- To clarify the possible causative role of manometric esophageal involvement
- Consecutive SSc-pts underwent pulmonary function tests (PFT) and esophageal manometry
- Inclusion criteria: PFT were repeated >12 mo after baseline
- Primary endpoint: a decrease of ≥10% in forced vital capacity (FVC)
- Secondary endpoints: a decrease of ≥15% in carbon monoxide diffusing capacity (DLCO) and a decrease of ≥20% in FVC
- 105 pts: 45 diffuse SSc, median disease duration 2.0 yrs:
- 23% had a FVC below 80%
- 59% had a DLCO below 80%, and
- 54% had severe esophageal hypomotility at baseline
- Over a period of 72±46 months:
- 29 pts (28%) displayed a decrease of ≥10% in FVC
- 39 of 98 pts (40%) displayed DLCO decline, and
- 19 pts (18%) displayed a decrease of ≥20% in FVC
- Multivariate analysis: diffuse SSc was a significant predictor for a decrease of ≥10% in FVC
- No other predictor of a decrease in pulmonary function was identified
Today in Connective Tissue Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis
Journal of Rheumatology, 11/20/09
The clinical course of polymyalgia rheumatica in Chinese
Clinical Rheumatology, 11/19/09
Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay
Scandinavian Journal of Rheumatology , 11/19/09
Sponsor
Article Search
Sponsor